Roche Announces US Food and Drug Administration Approval of Xofluza (Baloxavir Marboxil) for Influenza

被引：0
|
作者：
Kaye, Donald
机构：
来源：
CLINICAL INFECTIOUS DISEASES | 2019年 / 68卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：I / II
页数：2
相关论文
共 50 条
  • [1] Baloxavir Marboxil (Xofluza) for Influenza
    Erlich, Deborah R.
    [J]. AMERICAN FAMILY PHYSICIAN, 2019, 100 (12) : 776 - 777
  • [2] Baloxavir Marboxil (Xofluza) for Treatment of Influenza
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1561): : 193 - 196
  • [3] Biota announces US Food and Drug Administration approval for Relenza® for the treatment of influenza
    不详
    [J]. AUSTRALASIAN BIOTECHNOLOGY, 1999, 9 (03) : 139 - 140
  • [4] BALOXAVIR MARBOXIL: THE NEW INFLUENZA DRUG ON THE MARKET
    不详
    [J]. MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2019, 123 (03): : 452 - 452
  • [5] Baloxavir marboxil: the new influenza drug on the market
    O'Hanlon, Ryan
    Shaw, Megan L.
    [J]. CURRENT OPINION IN VIROLOGY, 2019, 35 : 14 - 18
  • [6] Baloxavir Marboxil: An Original New Drug against Influenza
    Dufrasne, Francois
    [J]. PHARMACEUTICALS, 2022, 15 (01)
  • [7] Introducing the new anti-influenza drug, baloxavir marboxil
    Fujita, Jiro
    [J]. RESPIRATORY INVESTIGATION, 2020, 58 (01) : 1 - 3
  • [8] US Food and Drug Administration and Design of Drug Approval Studies
    Woloshin, Steven
    Schwartz, Lisa M.
    Frankel, Brittney
    Faerber, Adrienne
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (20): : 2163 - 2165
  • [9] Improved Synthesis of Key Intermediate of Baloxavir Marboxil, an Anti-Influenza Drug
    Hu, Zhenfei
    Li, Maocheng
    Meng, Xin
    Guo, Bin
    [J]. CHEMISTRYSELECT, 2022, 7 (29):
  • [10] US Food and Drug Administration approval of esketamine and brexanolone
    Cristea, Ioana A.
    Naudet, Florian
    [J]. LANCET PSYCHIATRY, 2019, 6 (12): : 975 - 977
12345